RGT 5.17% 30.5¢ argent biopharma limited

Christmas, page-25

  1. 2,484 Posts.
    lightbulb Created with Sketch. 80

    The Company was recently awarded a full Good Manufacturing Practice (GMP) licence for its European Production and Manufacturing facility in Slovenia, following production of its first commercial batch of epilepsy medicine, CannEpil™. Receipt of this certification has advanced MGC Pharma towards the final stages for commercialisation which will follow the completion of final tests, CannEpilTM becoming available for supply in Australia under the Authorised Prescriber Scheme by the TGA, and its final validation.


    Source



 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
30.5¢
Change
0.015(5.17%)
Mkt cap ! $14.00M
Open High Low Value Volume
29.0¢ 30.5¢ 29.0¢ $577 1.938K

Buyers (Bids)

No. Vol. Price($)
3 7344 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 313 1
View Market Depth
Last trade - 11.40am 11/07/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.